1-Acetyl-4-methylpiperazine hydrochlorideNicotinic agonist CAS# 144205-68-5 |
- CYT387 sulfate salt
Catalog No.:BCC1506
CAS No.:1056636-06-6
- Baricitinib phosphate
Catalog No.:BCC1401
CAS No.:1187595-84-1
- JAK2 Inhibitor V, Z3
Catalog No.:BCC1667
CAS No.:195371-52-9
- Bardoxolone methyl
Catalog No.:BCC1400
CAS No.:218600-53-4
- Ruxolitinib (INCB018424)
Catalog No.:BCC1276
CAS No.:941678-49-5
Quality Control & MSDS
Chemical structure
3D structure
Number of papers citing our products
| Cas No. | 144205-68-5 | SDF | Download SDF |
| PubChem ID | 53411727 | Appearance | Powder |
| Formula | C7H15ClN2O | M.Wt | 178.66 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble to 50 mM in water | ||
| Chemical Name | 1-(4-methylpiperazin-1-yl)ethanone;hydrochloride | ||
| SMILES | CC(=O)N1CCN(CC1)C.Cl | ||
| Standard InChIKey | MQTVMZTUPOGGGV-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C7H14N2O.ClH/c1-7(10)9-5-3-8(2)4-6-9;/h3-6H2,1-2H3;1H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Structural analog of acetylcholine that acts as a nAChR agonist. |
1-Acetyl-4-methylpiperazine hydrochloride Dilution Calculator
1-Acetyl-4-methylpiperazine hydrochloride Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.5972 mL | 27.9861 mL | 55.9722 mL | 111.9445 mL | 139.9306 mL |
| 5 mM | 1.1194 mL | 5.5972 mL | 11.1944 mL | 22.3889 mL | 27.9861 mL |
| 10 mM | 0.5597 mL | 2.7986 mL | 5.5972 mL | 11.1944 mL | 13.9931 mL |
| 50 mM | 0.1119 mL | 0.5597 mL | 1.1194 mL | 2.2389 mL | 2.7986 mL |
| 100 mM | 0.056 mL | 0.2799 mL | 0.5597 mL | 1.1194 mL | 1.3993 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Indoxacarb
Catalog No.:BCN2263
CAS No.:144171-61-9
- Ledipasvir acetone
Catalog No.:BCC4046
CAS No.:1441674-54-9
- Eprosartan Mesylate
Catalog No.:BCC4658
CAS No.:144143-96-4
- Fmoc-Glu-OAll
Catalog No.:BCC3490
CAS No.:144120-54-7
- Fmoc-Asp-OAll
Catalog No.:BCC3086
CAS No.:144120-53-6
- Tarasaponin VII
Catalog No.:BCN2684
CAS No.:144118-18-3
- Deltarasin hydrochloride
Catalog No.:BCC4270
CAS No.:1440898-82-7
- Deltarasin
Catalog No.:BCC1524
CAS No.:1440898-61-2
- Febuxostat
Catalog No.:BCC2556
CAS No.:144060-53-7
- 6-O-Syringoylajugol
Catalog No.:BCN6246
CAS No.:144049-72-9
- Piclamilast
Catalog No.:BCC6215
CAS No.:144035-83-6
- BRD73954
Catalog No.:BCC5652
CAS No.:1440209-96-0
- YYA-021
Catalog No.:BCC5346
CAS No.:144217-65-2
- Dehydroadynerigenin glucosyldigitaloside
Catalog No.:BCN1568
CAS No.:144223-70-1
- ML 337
Catalog No.:BCC6345
CAS No.:1443118-44-2
- 1-Deazaadenosine
Catalog No.:BCC6204
CAS No.:14432-09-8
- Trilepisflavan
Catalog No.:BCN6786
CAS No.:1443218-16-3
- YM 26734
Catalog No.:BCC7396
CAS No.:144337-18-8
- Nemoralisin C
Catalog No.:BCN7680
CAS No.:1443421-84-8
- CCG 203971
Catalog No.:BCC5601
CAS No.:1443437-74-8
- GSK2838232
Catalog No.:BCC6372
CAS No.:1443461-21-9
- 8-(7-Hydroxy-3,7-dimethyl-2,5-octadienyloxy)psoralen
Catalog No.:BCN1567
CAS No.:144398-34-5
- 3-Oxopomolic acid methyl ester
Catalog No.:BCN3723
CAS No.:14440-23-4
- Canophyllal
Catalog No.:BCN7441
CAS No.:14440-40-5
Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells.[Pubmed:9572289]
J Neurochem. 1998 May;70(5):2028-37.
The present study further investigated whether nicotinic acetylcholine receptor (nAChR) subtypes differ in their ability to up-regulate following chronic exposure to nicotinic agonists. Seven nicotinic agonists were studied for their ability to influence the number of chick alpha4beta2 nAChR binding sites stably transfected in fibroblasts (M10 cells) following 3 days of exposure. The result showed a positive correlation between the Ki values for binding inhibition and EC50 values for agonist-induced alpha4beta2 nAChR up-regulation. The effects of epibatidine and nicotine were further investigated in human neuroblastoma SH-SY5Y cells (expressing alpha3, alpha5, beta2, and beta4 nAChR subunits). Nicotine exhibited a 14 times lower affinity for the nAChRs in SH-SY5Y cells as compared with M10 cells, whereas epibatidine showed similar affinities for the nAChRs expressed in the two cell lines. The nicotine-induced up-regulation of nAChR binding sites in SH-SY5Y cells was shifted to the right by two orders of magnitude as compared with that in M10 cells. The epibatidine-induced up-regulation of nAChR binding sites in SH-SY5Y cells was one-fourth that in M10 cells. The levels of mRNA of the various nAChR subunits were measured following the nicotinic agonist exposure. In summary, the various nAChR subtypes show different properties in their response to chronic stimulation.
Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist.[Pubmed:7831430]
Psychopharmacology (Berl). 1993;110(3):347-54.
The novel nicotinic agonist 1-acetyl-4-methylpiperazine (AMP) has been studied in ligand-binding and behavioural studies. AMP methiodide potently inhibited [3H]-(-)-nicotine and [125I]-alpha-bungarotoxin binding to P2 membranes from rat brain and [125I]-alpha-bungarotoxin binding to rat skeletal muscles. AMP HCl also inhibited nicotinic binding, but it was 100 times less potent than AMP methiodide. In behavioural studies, AMP HCl reduced locomotor activity of experimentally naive rats and mecamylamine blocked this effect. In rats receiving (-)-nicotine chronically, AMP HCl did not increase locomotor activity consistently or to the same extent as (-)-nicotine. In rats trained to discriminate (-)-nicotine from saline in a two-bar operant conditioning procedure with food reinforcement, there was generalization to AMP HCl, but only at doses that reduced the overall rate of responding. The potency and effectiveness of AMP relative to (-)-nicotine varied across the different behavioural procedures. The results suggest that the pharmacodynamic action of AMP differs from that of (-)-nicotine and that it usefully extends the range of agonists that can be used as probes for central nicotinic mechanisms.
